How New CMS Prior-Authorization Reporting Rules in 2026 Could Change Transparency for Patients and Clinicians

Bottom line: Beginning in 2026, new federal rules require many health insurers to publicly report how they use prior authorization—how often requests are approved, denied, or delayed, and how long decisions take. The goal is to give patients, clinicians, and policymakers clearer insight into a process that can directly affect access to care.

As a public health reporter, I hear from readers who are confused or frustrated by prior authorization. These new reporting requirements from the Centers for Medicare & Medicaid Services (CMS) are designed to bring more transparency to that system.

What Is Prior Authorization?

Prior authorization (sometimes called “pre-approval”) is when your health insurer requires your doctor to get approval before covering certain medications, procedures, imaging tests, or services.

It’s common for:

Specialty medications, including some cancer and autoimmune treatments
Advanced imaging like MRIs or CT scans
Certain surgeries or outpatient procedures
Some dental and oral-surgery services under medical plans

Insurers say prior authorization helps control costs and ensure treatments are medically appropriate. Clinicians and patient advocates often argue that it can delay necessary care and add administrative burden.

What Changed Under the New CMS Rule?

In January 2024, CMS finalized a rule known as the Interoperability and Prior Authorization Final Rule (CMS-0057-F). According to CMS, this rule applies to Medicare Advantage plans, Medicaid and CHIP managed care plans, and Qualified Health Plans on the federally facilitated Marketplace.

Several parts of the rule take effect over time, but beginning in 2026, affected insurers must publicly report prior authorization metrics annually.

According to CMS, required reporting includes:

The number of prior authorization requests received
The number approved and denied
The percentage approved after appeal
The average time it takes to make a decision

The data must be posted in a way that is accessible to the public. CMS has said the aim is to improve accountability and allow patients and clinicians to better understand how plans use prior authorization.

Why Transparency Matters

For most patients, prior authorization happens behind the scenes. You may only learn about it when:

Your prescription is delayed at the pharmacy
Your imaging test is rescheduled
Your doctor’s office calls to say approval is still pending

Until now, it has been difficult for patients to compare how often different plans deny requests or how quickly they respond. Public reporting could make patterns more visible.

If one plan denies significantly more requests than others, or takes longer to respond, that information may influence:

Plan selection during open enrollment
Employer contracting decisions
Policy discussions at the state or federal level

Mainstream coverage, including reporting from Reuters, has noted that the rule is part of a broader federal effort to reduce administrative burden and speed up decisions using electronic systems.

Other Key Parts of the Rule

Beyond reporting, the CMS rule also requires affected insurers to:

Send prior authorization decisions within specific timeframes (generally 7 calendar days for standard requests and 72 hours for expedited requests, with some variation by program)
Provide specific reasons for denials
Support electronic prior authorization processes through standardized APIs (application programming interfaces)

These technical requirements are intended to allow electronic health record systems to communicate directly with insurers, potentially reducing paperwork and manual back-and-forth.

What This Could Mean for Patients

1. More Information During Plan Shopping

If reporting is clear and easy to find, patients enrolling in Medicare Advantage or Marketplace coverage may be able to see how frequently plans deny prior authorization requests.

That does not automatically tell you whether a plan is “good” or “bad.” Some plans may cover different populations with more complex health needs. But it provides context that has not previously been widely available.

2. Clearer Denial Explanations

Under the rule, plans must give specific reasons for prior authorization denials. For patients, that can make it easier to understand whether:

The request lacked documentation
The service is excluded under the plan
The insurer believes an alternative treatment is appropriate

Clearer explanations can help patients and clinicians decide whether to appeal.

3. Potentially Faster Decisions

CMS expects electronic systems and defined timelines to reduce delays. However, real-world impact will depend on how effectively insurers and health systems implement these tools.

It is too early to say whether patients will consistently experience shorter wait times. Reporting data beginning in 2026 may help answer that question.

What This Means for Clinicians

Doctors, nurses, and practice staff often spend significant time managing prior authorization paperwork. Public reporting could:

Highlight plans with high denial or appeal rates
Support advocacy efforts for further reform
Encourage more standardized, electronic workflows

Professional associations, including the American Medical Association, have long raised concerns about administrative burden related to prior authorization. Public data may strengthen discussions about policy changes.

What Remains Uncertain

Transparency does not automatically equal simplification. Key open questions include:

How easy will it be for patients to find and understand the reported data?
Will reported metrics be comparable across plans and states?
Will public reporting change insurer behavior in measurable ways?

It may take several years of publicly available data to see meaningful trends.

How This Connects to Access and Health Equity

Delays in care can disproportionately affect people with limited transportation, hourly jobs, language barriers, or complex chronic conditions. Greater transparency may help policymakers identify whether certain populations are experiencing higher denial rates or longer delays.

However, reporting alone does not eliminate disparities. Broader system changes—such as clearer clinical guidelines, adequate provider networks, and simplified appeals processes—also play a role.

What You Can Do as a Patient

Ask early: When your clinician recommends a test or treatment, ask whether prior authorization is required.
Understand timelines: For urgent issues, make sure your clinician flags the request as expedited if appropriate.
Request written explanations: If denied, ask for the specific reason and how to appeal.
Compare plans carefully: During enrollment periods, review available information about coverage rules and prior authorization practices.

The Takeaway

Starting in 2026, many Medicare Advantage, Medicaid managed care, and Marketplace plans must publicly report how they use prior authorization. That shift toward transparency could give patients and clinicians clearer insight into approval rates, denials, and decision timelines.

It does not eliminate prior authorization—but it may make the process more visible and, over time, more accountable.

For patients navigating coverage decisions or waiting on approval for care, that visibility could matter.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.